Vanda Pharmaceuticals to Announce Second Quarter 2014 Financial Results on August 7, 2014 Conference Call and Webcast to Follow PR Newswire WASHINGTON, July 17, 2014 WASHINGTON, July 17, 2014 /PRNewswire/ --Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced it will release results for the second quarter of 2014 on Thursday, August 7, 2014, before the market opens. The Company will host a conference call at 10:00 AM ET on Thursday, August 7, 2014, during which Vanda management will discuss the second quarter 2014 financial results and other corporate activities. To participate in the conference call, please dial 1-800-708-4540 (domestic) or 1-847-619-6397 (international) and use passcode 37729521. The conference call will be broadcast simultaneously and archived on the Company's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software. A replay of the call will be available on Thursday, August 7, 2014, beginning at 12:30 PM ET and will be accessible until Thursday, August 14, 2014, at 11:59 PM ET. The replay call-in number is 1-888-843-7419 for domestic callers and 1-630-652-3042 for international callers. The passcode number is 37729521. ABOUT VANDA PHARMACEUTICALS INC.: Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com. Investor Contact: Jim Kelly Senior Vice President & Chief Financial Officer Vanda Pharmaceuticals, Inc. (202) 734-3428 email@example.com SOURCE Vanda Pharmaceuticals Inc. Website: http://www.vandapharma.com
Vanda Pharmaceuticals to Announce Second Quarter 2014 Financial Results on August 7, 2014
Press spacebar to pause and continue. Press esc to stop.